Article Text

Download PDFPDF
1 The cathepsin-L inhibitor CAA0225 protects against myocardial ischaemia-reperfusion injury
  1. W He,
  2. CS McCarroll,
  3. K Nather,
  4. EBA Elliott,
  5. SA Nicklin,
  6. CM Loughrey
  1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK


Ischaemia-reperfusion (IR) injury contributes to the cardiac damage following myocardial infarction and paradoxically reduces the benefits of reperfusion therapy. In patients with ischaemic heart disease, cathepsin-L is elevated in the serum and correlates with disease severity. Our data demonstrate that cathepsin-L released from ex vivo rat hearts after ischaemia, and the cathepsin-L inhibitor CAA0225 improves cardiac function during ischaemia-reperfusion ex vivo. However, the effects of the CAA0225 in in vivo hearts during ischaemia-reperfusion are unknown. We hypothesised that using CAA0225 in an in vivo mouse model of ischaemia-reperfusion would identify the role cathepsin-L plays during ischaemia-reperfusion. Ischaemia-reperfusion injury was induced by 45 min temporary coronary artery ligation and CAA0225 was given by intra-venous injection during ischaemia before reperfusion. Double-dye staining demonstrated no difference in area at risk between groups whereas CAA0225 significantly reduced infarct size to 73% of control. Echocardiography demonstrated significantly preserved left ventricular fractional shortening at 2 wk and 4 wk post-IR in CAA0225 treated mice compared with control mice. PV loop measurements demonstrated CAA0225 treated mice had higher developed pressure than control mice at 2 weeks post-IR. Ex vivo isolated rat cardiomyocytes demonstrated that ischemia-reperfusion increased calcium influx through L-type calcium channels, reduced sarcolemmal NCX extrusion and SERCA activity. While CAA0225 treatment normalised the abnormalities of intracellular calcium handling parameters back to control thus reducing calcium waves following ischaemia-reperfusion. These data demonstrate for the first time that CAA0225 protects against ischaemia-reperfusion injury in mice and the mechanism relates to the normalisation of abnormal calcium handling following ischaemia-reperfusion injury.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.